These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival. Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455 [TBL] [Abstract][Full Text] [Related]
10. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt. Melaragno MG; Cavet ME; Yan C; Tai LK; Jin ZG; Haendeler J; Berk BC J Mol Cell Cardiol; 2004 Oct; 37(4):881-7. PubMed ID: 15380678 [TBL] [Abstract][Full Text] [Related]
11. Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner. Zdżalik-Bielecka D; Kozik K; Poświata A; Jastrzębski K; Jakubik M; Miączyńska M Mol Cancer Res; 2022 Mar; 20(3):446-455. PubMed ID: 34782372 [TBL] [Abstract][Full Text] [Related]
12. GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance. Baumann C; Ullrich A; Torka R Mol Oncol; 2017 Oct; 11(10):1430-1447. PubMed ID: 28675785 [TBL] [Abstract][Full Text] [Related]
13. Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway. Li M; Ye J; Zhao G; Hong G; Hu X; Cao K; Wu Y; Lu Z Int J Mol Med; 2019 Sep; 44(3):982-994. PubMed ID: 31524235 [TBL] [Abstract][Full Text] [Related]
14. AXL regulates mesothelioma proliferation and invasiveness. Ou WB; Corson JM; Flynn DL; Lu WP; Wise SC; Bueno R; Sugarbaker DJ; Fletcher JA Oncogene; 2011 Apr; 30(14):1643-52. PubMed ID: 21132014 [TBL] [Abstract][Full Text] [Related]
15. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. Antony J; Tan TZ; Kelly Z; Low J; Choolani M; Recchi C; Gabra H; Thiery JP; Huang RY Sci Signal; 2016 Oct; 9(448):ra97. PubMed ID: 27703030 [TBL] [Abstract][Full Text] [Related]
17. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages. Gustafsson A; Fritz HKM; Dahlbäck B Exp Cell Res; 2017 Jun; 355(1):47-56. PubMed ID: 28327411 [TBL] [Abstract][Full Text] [Related]
18. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients. Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819 [TBL] [Abstract][Full Text] [Related]
19. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Kirane A; Ludwig KF; Sorrelle N; Haaland G; Sandal T; Ranaweera R; Toombs JE; Wang M; Dineen SP; Micklem D; Dellinger MT; Lorens JB; Brekken RA Cancer Res; 2015 Sep; 75(18):3699-705. PubMed ID: 26206560 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. Kariolis MS; Miao YR; Diep A; Nash SE; Olcina MM; Jiang D; Jones DS; Kapur S; Mathews II; Koong AC; Rankin EB; Cochran JR; Giaccia AJ J Clin Invest; 2017 Jan; 127(1):183-198. PubMed ID: 27893463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]